Simple Summary The combination of positron emission tomography (PET)-diagnostics with
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …

Objectives To compare prostate-specific membrane antigen (PSMA) PET with
multiparametric MRI (mpMRI) in the diagnosis of pretreatment prostate cancer (PCa) …

Purpose Multiparametric MRI (mpMRI) has been promoted as an auxiliary diagnostic tool for
prostate biopsy. However, prostate-specific membrane antigen (PSMA) including 68 Ga …

Despite the developments of the last few years, metastatic castration-resistant prostate
cancer (PC) remains a deadly disease. Until recently, almost all guidelines recommended …

Initial staging of prostate cancer (PCa) is usually performed with conventional imaging (CI),
involving computed tomography (CT) and bone scanning (BS). The aim of this study was to …

Prostate cancer (PCa) is the most frequently diagnosed cancer worldwide and the second
most common cause of cancer-related deaths among men. Progress in molecular imaging …

For patients presenting with prostate imaging reporting and data system (PI-RADS) 3/4
findings on magnetic resonance imaging (MRI) examinations, the standard recommendation …

Purpose High PSMA expression might be correlated with structural characteristics such as
growth patterns on histopathology, not recognized by the human eye on MRI images. Deep …

Simple Summary Treating patients for metastatic prostate cancer based on the information of
PSMA-PET bears the risk to “under-or overtreat” patients, given that many lesions seen only …

Purpose To assess if PSMA PET quantitative parameters are associated with pathologic
ISUP grade group (GG) and upgrading/downgrading. Methods PCa patients undergoing …